Development and validation of a hydrophilic interaction chromatography-tandem mass spectrometry for quantification of nicotine and its metabolites in human maternal and cord sera

Biomedical Chromatography

Volumn 25, Issue 4, 2011, Pages 503-510

  Iwasaki, Yusuke ^a   Goto, Masato ^a   Mochizuki, Keisuke ^a   Terayama, Emi ^a   Ito, Rie ^a   Saito, Koichi ^a   Sugino, Norihiro ^b   Makino, Tsunehisa ^c   Nakazawa, Hiroyuki ^a  

^a HOSHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Toubu Hospital   (Japan)

Author keywords

Hydrophilic interaction chromatography; Metabolite; Nicotine; Serum; Tandem mass spectrometry

Indexed keywords

BIOMOLECULES; BODY FLUIDS; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NICOTINE; PHASE SEPARATION;

ANALYTES; CORD SERUM; HILIC-MS/MS; HUMAN MATERNAL SERUMS; HYDROPHILIC INTERACTION CHROMATOGRAPHY; SERUM; SOLID-PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY; VALIDATED METHODS;

METABOLITES;

3' HYDROXYCOTININE; COTININE; NICOTINE; NORNICOTINE;

ACCURACY; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MATERNAL SERUM; METABOLITE; PRENATAL EXPOSURE; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY; SMOKING; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD; VALIDATION PROCESS;

EID: 79952221103     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1475     Document Type: Article

References (34)

1. Abu-Qare AW and Abou-Donia MB. Quantification of nicotine, chlorpyrifos and their metabolites in rat plasma and urine using high-performance liquid chromatography. Journal of Chromatography B, Biomedical Sciences and Applications. 2001; 757: 295-300.
2. Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. Journal of Chromatography 1990; 499: 177-196.
3. Andres RL and Day MC. Perinatal complications associated with maternal tobacco use. Seminars in Neonatology: SN 2000; 5: 231-241.
4. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews 1996; 18: 188-204.
5. Benowitz NL, Jacob P 3rd, Fong I and Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. The Journal of Pharmacology and Experimental Therapeutics 1994; 268: 296-303.
6. Bernert JT Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, Ann Q, Covey TR, Whitfield WE, Gunter EW, Miller BB, Patterson DG Jr, Needham LL, Hannon WH and Sampson EJ. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clinical Chemistry 1997; 43: 2281-2291.
7. Bouckaert A. Smoking during pregnancy: foetal growth retardation and other risks for the newborn. Statistics in Medicine 2000; 19: 239-254.
8. Bowman TS, Gaziano JM, Buring JE and Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. Journal of the American College of Cardiology 2007; 50: 2085-2092.
9. Chambers E, Wagrowski-Diehl DM, Lu Z and Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2007; 852: 22-34.
10. Davoli E, Stramare L, Fanelli R, Diomede L and Salmona M. Rapid solid-phase extraction method for automated gas chromatographic-mass spectrometric determination of nicotine in plasma. Journal of Chromatography B, Biomedical Sciences and Applications 1998; 707: 312-316.
11. FDA. Guidance for Industry. Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2001.
12. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A and Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. The Lancet Oncology 2008; 9: 649-656.
13. Hukkanen J, Jacob III P and Benowitz NL. Metabolism and disposition kinetics of nicotine: Pharmacological Reviews 2005; 57: 79-115.
14. Iwasaki Y, Hoshi M, Ito R, Saito K and Nakazawa H. Analysis of glutathione and glutathione disulfide in human saliva using hydrophilic interaction chromatography with mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 839: 74-79.
15. Jacob P 3rd, Wu S, Yu L and Benowitz NL. Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2000; 23: 653-661.
16. Lockman PR, McAfee G, Geldenhuys WJ, Van der Schyf CJ, Abbruscato TJ and Allen DD. Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure. The Journal of Pharmacology and Experimental Therapeutics 2005; 314: 636-642.
17. Man CN, Gam LH, Ismail S, Lajis R and Awang R. Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography-mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 844: 322-327.
18. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019-3030.
19. McManus KT, deBethizy JD, Garteiz DA, Kyerematen GA and Vesell ES. A new quantitative thermospray LC-MS method for nicotine and its metabolites in biological fluids. Journal of Chromatographic Science 1990; 28: 510-516.
20. Miller EI, Norris HR, Rollins DE, Tiffany ST and Wilkins DG. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2010; 878: 725-737.
21. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR and Hurt RD. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical Chemistry 2002; 48: 1460-1471.
22. Murphy SE, Villalta P, Ho SW and von Weymarn LB. Analysis of [3', 3'-d(2)]-nicotine and [3', 3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2007; 857: 1-8.
23. Okano K, Hinohara M, Iwasaki Y, Ito R, Saito K, Izumi S-I, Makino T and Nakazawa H. Determination of nicotine and cotinine in human serum for evaluation of tobacco smoke exposure by hydrophilic interaction chromatography/mass spectrometry. Bunseki Kagaku 2007; 56: 785-790.
24. Pacifici R, Pichini S, Altieri I, Rosa M, Bacosi A, Caronna A and Zuccaro P. Determination of nicotine and two major metabolites in serum by solid-phase extraction and high-performance liquid chromatography, and high-performance liquid chromatography-particle beam mass spectrometry. Journal of Chromatography 1993; 612: 209-213.
25. Pérez-Stable EJ, Benowitz NL and Marín G. Is serum cotinine a better measure of cigarette smoking than self-report? Preventive Medicine 1995; 24: 171-179.
26. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA and Maurer KR. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA: the Journal of the American Medical Association 1996; 275: 1233-1240.
27. Pope M, Ashley MJ and Ferrence R. The carcinogenic and toxic effects of tobacco smoke: are women particularly susceptible? The Journal of Gender-specific Medicine: JGSM: the Official Journal of the Partnership for Women's Health at Columbia 1999; 2: 45-51.
28. Russell MA and Feyerabend C. Cigarette smoking: a dependence on high-nicotine boli. Drug Metabolism Reviews 1978; 8: 29-57.
29. Seltzer V. Smoking as a risk factor in the health of women. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 2003; 82: 393-397.
30. Shakleya DM and Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877: 3537-3542.
31. Shou WZ and Naidong W. Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 825: 186-192.
32. Windham GC, Hopkins B, Fenster L and Swan SH. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology (Cambridge, Mass.) 2000; 11: 427-433.
33. Xu X, Iba MM and Weisel CP. Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry. Clinical Chemistry 2004; 50: 2323-2330.
34. Yu H, Straubinger RM, Cao J, Wang H and Qu J. Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry. Journal of Chromatography A 2008; 1210: 160-167.